These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 38551039)

  • 1. Current Concepts in the Molecular Mechanisms and Management of Diabetic Neuropathy by Pharmacotherapeutics and Natural Compounds.
    Shivam ; Gupta AK; Kumar S
    Cent Nerv Syst Agents Med Chem; 2024; 24(3):264-280. PubMed ID: 38551039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets.
    Dewanjee S; Das S; Das AK; Bhattacharjee N; Dihingia A; Dua TK; Kalita J; Manna P
    Eur J Pharmacol; 2018 Aug; 833():472-523. PubMed ID: 29966615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Neuropathy: An Overview of Molecular Pathways and Protective Mechanisms of Phytobioactives.
    Hashim M; Badruddeen ; Akhtar J; Khan MI; Ahmad M; Islam A; Ahmad A
    Endocr Metab Immune Disord Drug Targets; 2024; 24(7):758-776. PubMed ID: 37867264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Insights of Plant Phytochemicals Against Diabetic Neuropathy.
    Balkrishna A; Pathak R; Bhatt S; Arya V
    Curr Diabetes Rev; 2023; 19(9):e250822207994. PubMed ID: 36028963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic peripheral neuropathy: current perspective and future directions.
    Singh R; Kishore L; Kaur N
    Pharmacol Res; 2014 Feb; 80():21-35. PubMed ID: 24373831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Neuroprotective Role of Glucagon-like Peptide-1 Agonists in Diabetic Neuropathy: Current Perspective and Future Directions.
    Mehta K; Behl T; Kumar A; Uddin MS; Zengin G; Arora S
    Curr Protein Pept Sci; 2021; 22(1):4-18. PubMed ID: 33292149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors.
    Didangelos T; Veves A
    Curr Vasc Pharmacol; 2020; 18(2):158-171. PubMed ID: 31109280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic neuropathy: mechanisms to management.
    Edwards JL; Vincent AM; Cheng HT; Feldman EL
    Pharmacol Ther; 2008 Oct; 120(1):1-34. PubMed ID: 18616962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of advanced glycation end products in diabetic neuropathy.
    Sugimoto K; Yasujima M; Yagihashi S
    Curr Pharm Des; 2008; 14(10):953-61. PubMed ID: 18473845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting neuroinflammation in distal symmetrical polyneuropathy in diabetes.
    Chong ZZ; Menkes DL; Souayah N
    Drug Discov Today; 2024 Aug; 29(8):104087. PubMed ID: 38969091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2: a potential therapeutic target for diabetic neuropathy.
    Kumar A; Mittal R
    Inflammopharmacology; 2017 Aug; 25(4):393-402. PubMed ID: 28353124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways.
    Hussain N; Adrian TE
    Curr Diabetes Rev; 2017; 13(5):488-497. PubMed ID: 27341846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of oxidative stress in the development of diabetic neuropathy].
    Sztanek F; Molnárné Molnár Á; Balogh Z
    Orv Hetil; 2016 Dec; 157(49):1939-1946. PubMed ID: 27917671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbal Remedies: A Boon for Diabetic Neuropathy.
    Tiwari R; Siddiqui MH; Mahmood T; Bagga P; Ahsan F; Shamim A
    J Diet Suppl; 2019; 16(4):470-490. PubMed ID: 29580105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Detailed Review of Molecular Pathways and Mechanisms Responsible for the Development and Aggravation of Neuropathy and Nephropathy in Diabetes.
    Chandra P; Sachan N; Saraswat N; Vyawahare N
    Curr Mol Pharmacol; 2024; 17(1):e280323215026. PubMed ID: 37018534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Insights into the Pathophysiology of Diabetic Neuropathy: Implications of Malfunctioning Glia and Discovery of Novel Therapeutic Targets.
    Rahman MH; Jha MK; Suk K
    Curr Pharm Des; 2016; 22(6):738-57. PubMed ID: 26635266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenic Mechanisms of Diabetic Neuropathy].
    Sango K; Yako H; Takaku S; Niimi N
    Brain Nerve; 2024 May; 76(5):671-680. PubMed ID: 38741511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Neuropathies.
    Elafros MA; Callaghan BC
    Continuum (Minneap Minn); 2023 Oct; 29(5):1401-1417. PubMed ID: 37851036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.